Skip to content
value.today

Niki BioSolutions, Inc.: valuation

What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.

Cash-flow value

Fewer than two of the last three years have both cash from operations and capital spending on file.

Price to bookPrice to book of Biotechnology: $72 M to $285 M, median $105 M$0 M$77 M$154 M$231 M$308 M

Your own DCF model

A full discounted-cash-flow model of Niki BioSolutions, Inc., started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.

Open the DCF model

Against the industry Biotechnology

Multiples of its companies with a market value at most 60 days old, times Niki BioSolutions, Inc.'s own figures of FY2025.

Values from the peers' multiples
MultiplePeers (25th / median / 75th)Niki BioSolutions, Inc.Applied toValue (25th to 75th)Companies
Price to book3.1× / 4.5× / 12.3×—book equity $23 M$72 M to $285 M70

Against its own history

Niki BioSolutions, Inc.'s multiples at each month end with a market cap on file, Jan 2020 to Mar 2026, each against its own median.

Price to book

0.3×

Now below its median of 1.0×, in the bottom quarter of its range; range 0.3× to 13.6× over 7 months.

0×3×7×10×14×2020202120222023202420252026Price to book 0×Median 1×

As of Mar 8, 2026

The statements it starts from

USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.

Figures from the annual statements
Fiscal yearRevenueNet incomeCash from operationsCapital spendingFree cash flowNet debtSource
FY2025to Dec 31, 2025—$-1 M$-2 M———SEC annual report (10-K, 20-F)
FY2024to Dec 31, 2024—$-4 M$-1 M———SEC annual report (10-K, 20-F)
FY2023to Dec 31, 2023$0 M$-3 M$-8 M$0 M$-8 M—SEC annual report (10-K, 20-F)
FY2022to Dec 31, 2022$1 M$-10 M$-12 M$0 M$-13 M$-5 MSEC annual report (10-K, 20-F)
FY2021to Dec 31, 2021$2 M$-25 M$-15 M$0 M$-15 M$-8 MSEC annual report (10-K, 20-F)
FY2020to Dec 31, 2020—$5 M$-16 M$0 M$-16 M$-3 MSEC annual report (10-K, 20-F)